Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.02 USD | -2.78% | -9.69% | -0.67% |
May. 13 | Oppenheimer Adjusts Price Target on Soleno Therapeutics to $59 From $65, Maintains Outperform Rating | MT |
May. 10 | Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.67% | 1.5B | |
+9.93% | 118B | |
+9.90% | 106B | |
-11.18% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.66% | 15.97B | |
+6.79% | 14.03B | |
+16.22% | 11.67B |
- Stock Market
- Equities
- SLNO Stock
- News Soleno Therapeutics, Inc.
- Soleno Therapeutics Insider Sold Shares Worth $784,645, According to a Recent SEC Filing